These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1665417)

  • 21. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms and frequency of resistance to temafloxacin.
    Appelbaum PC
    Am J Med; 1991 Dec; 91(6A):27S-30S. PubMed ID: 1662892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tosufloxacin tosilate].
    Shimada K
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria.
    Kato N; Kato H; Tanaka-Bando K; Watanabe K; Ueno K
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S31-5. PubMed ID: 8953104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro activity of temafloxacin, against gram-positive bacteria.
    Mandell LA; Lawrence T; Rotstein C; Gorzynski EA; Beam TR; Amsterdam D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():15-24. PubMed ID: 1664826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
    Kuznetsovoĭ SM
    Antibiot Khimioter; 1998; 43(2):40-1. PubMed ID: 9551172
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluoroquinolones in the treatment of human infection: the role of temafloxacin.
    Am J Med; 1991 Dec; 91(6A):1S-171S. PubMed ID: 1662876
    [No Abstract]   [Full Text] [Related]  

  • 32. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Degener J; Forsgren A; Schito GC; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):283-4. PubMed ID: 8050449
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR
    Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 36. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A; Bethune L; Phillips I
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Molinari G; Schito GC
    Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study.
    Finegold SM; Molitoris E; Reeves D; Wexler HM
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():25-30. PubMed ID: 1664827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.